Granuloma formation in discoid lupus erythematosus: a novel microscopic feature
Keywords:
Discoid lupus erythematosus (DLE), sebaceous granulomasAbstract
Background Lupus erythematosus is an autoimmune disease with marked pleotropism. If several systems are involved then the disease is named as systemic lupus erythematosus (SLE) and if skin is exclusively involved the term discoid lupus erythematosus (DLE) is used. One of the several histopathological features of DLE includes periappendageal inflammation. This may at times completely wipe out sebaceous glands forming sebaceous granulomas. Objective To determine the frequency of sebaceous granulomas formation in discoid lupus erythematosus. Materials and methods In this prospective observational study was conducted at the Departments of Dermatology and Pathology, Pakistan Institute of Medical Sciences, Islamabad. 100 cases of DLE spanning over two years and with the age range of 3 years to 70 years were examined for the presence of sebaceous granuloma. Other features of DLE like hyperkeratosis, follicular plugging, epidermal atrophy, basal layer vacuolization, basement membrane deposits, pigmentary incontinence, perivascular inflammation, periappendageal inflammation, and collagen damage were also noted. Results Out of these 100 cases, 8 cases contained sebaceous granulomas. These granulomas were composed of epithelioid cells, foreign body giant cells containing partially digested sebaceous material and a few lymphoctytes. Conclusion Sebaceous granulomas formation was seen in 8% cases of DLE cases. This feature must be recognized both by dermatologists and pathologist so that diagnosis of DLE may not be distracted and erroneous diagnosis due to presence of granulomas may not be rendered.ÂReferences
Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 2003; 4: 449-65.
Weber F, Schmuth M, Fritsch P, Sepp N. Lymphocytic infiltration of the skin is a photosensitive variant of lupus erythematosus: evidence by phototesting. Br J Dermatol 2001; 144: 292-6.
Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001; 28:1-23.
Baima B, Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001; 144: 958-66.
Parodi A, Caproni M, Cardinali C et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. Dermatology 2000; 200: 6-10.
Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol 2006; 47: 13-27.
Housman TS, Jorizzo JL, McCarty MA et al. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol 2003; 139: 50-4.
Heffernan MP, Nelson MM, Smith DI, Chung JH. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. Arch Dermatol 2005; 141: 1170-1.
Wenzel J, Brahler S, Bauer R et al. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol 2005; 153: 157-62.
Al Venketaram MN, Bhushnurmath SR. Cutaneous lupus erythematosus: comparison of direct immunofluorescence findings with histopathology. Int J Dermatol 1995; 34: 480-2.
Jerdan MS, Hood AF, Moore GW, Callen JP. Histopathologic comparison of the subsets lupus erythematosus. Arch Dermatol 1990; 126: 52-5.
Qureshi R, Shaikh R, Haque AU. Chronic granulomatous inflammatory disorders of skin at a tertiary care hospital in Islamabad. Int J Pathol 2004; 2: 31-4.
Haque AU. In situ hemorrhage. Int J Pathol 2003; 1: 60.
Saeed M, Haque AU. Cutaneous laxa with granulomatous inflammation. Int J Pathol 2008; 6: 86-90.
Moatasim A, Haque AU. The value of individual microscopic features in diagnosis of cutaneous lupus erythematosus. Int J Pathol 2005; 3; 76-80.
